Structural studies on bio-active compounds. Part 11. Molecular modelling, crystallographic, and biochemical studies of the interactions of (±)-α-vinylserine with the enzyme serine hydroxymethyltransferase

Author(s):  
Saul J. B. Tendler ◽  
Carl H. Schwalbe ◽  
Michael D. Threadgill ◽  
Michael J. Tisdale ◽  
LaVerne Schirch
Molecules ◽  
2015 ◽  
Vol 20 (8) ◽  
pp. 14761-14776 ◽  
Author(s):  
Tomasz Wróbel ◽  
Urszula Kosikowska ◽  
Agnieszka Kaczor ◽  
Sylwia Andrzejczuk ◽  
Zbigniew Karczmarzyk ◽  
...  

Pathogens ◽  
2019 ◽  
Vol 8 (4) ◽  
pp. 169 ◽  
Author(s):  
Hesham Elshahawi ◽  
Sharifah Syed Hassan ◽  
Vinod Balasubramaniam

Zika virus is the latest addition to an ever-growing list of arboviruses that are causing outbreaks with serious consequences. A few mild cases were recorded between 1960 and 1980 until the first major outbreak in 2007 on Yap Island. This was followed by more severe outbreaks in French Polynesia (2013) and Brazil (2015), which significantly increased both Guillain-Barre syndrome and microcephaly cases. No current vaccines or treatments are available, however, recent studies have taken interest in the NS5 protein which encodes both the viral methyltransferase and RNA-dependent RNA polymerase. This makes it important for viral replication alongside other important functions such as inhibiting the innate immune system thus ensuring virus survival and replication. Structural studies can help design inhibitors, while biochemical studies can help understand the various mechanisms utilized by NS5 thus counteracting them might inhibit or abolish the viral infection. Drug repurposing targeting the NS5 protein has also proven to be an effective tool since hundreds of thousands of compounds can be screened therefore saving time and resources, moreover information on these compounds might already be available especially if they are used to treat other ailments.


2020 ◽  
Vol 3 (1) ◽  
Author(s):  
Jinxin Xu ◽  
Xiaowen Tang ◽  
Yiguang Zhu ◽  
Zhijun Yu ◽  
Kai Su ◽  
...  

AbstractAmine compounds biosynthesis using ω-transaminases has received considerable attention in the pharmaceutical industry. However, the application of ω-transaminases was hampered by the fundamental challenge of severe by-product inhibition. Here, we report that ω-transaminase CrmG from Actinoalloteichus cyanogriseus WH1-2216-6 is insensitive to inhibition from by-product α-ketoglutarate or pyruvate. Combined with structural and QM/MM studies, we establish the detailed catalytic mechanism for CrmG. Our structural and biochemical studies reveal that the roof of the active site in PMP-bound CrmG is flexible, which will facilitate the PMP or by-product to dissociate from PMP-bound CrmG. Our results also show that amino acceptor caerulomycin M (CRM M), but not α-ketoglutarate or pyruvate, can form strong interactions with the roof of the active site in PMP-bound CrmG. Based on our results, we propose that the flexible roof of the active site in PMP-bound CrmG may facilitate CrmG to overcome inhibition from the by-product.


Xenobiotica ◽  
1997 ◽  
Vol 27 (4) ◽  
pp. 319-340 ◽  
Author(s):  
D. F. V. LEWIS ◽  
P. J. EDDERSHAW ◽  
P. S. GOLDFARB ◽  
M. H. TARBIT

Sign in / Sign up

Export Citation Format

Share Document